Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Multiple-Dose, Single Period, Phase II/III Dose Response Study to Examine Transdermal Human Insulin in Adult Diabetic Patients

NCT05159453 is registered in ClinicalTrials.gov with Transdermal Delivery Solutions Corp as lead sponsor.

NCT NCT05159453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05159453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Multiple-Dose, Single Period, Phase II/III Dose Response Study to Examine Transdermal Human Insulin in Adult Diabetic Patients
Lead sponsor
Transdermal Delivery Solutions Corp
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
September 2, 2027
Completion date
December 15, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose, high blood